Radiofrequency ablation for hepatocellular carcinoma

Masaru Inagaki, Takahito Yagi, Hiroshi Sadamori, Hiroaki Matsuda, Hiroyoshi Matsukawa, Takashi Ishikawa, Noriaki Tanaka, Hidefumi Mimura, Kotaro Yasui, Susumu Kanazawa

Research output: Contribution to journalArticle

Abstract

We performed radiofrequency ablation (RFA) for 14 patients with hepatocellular carcinoma (HCC) between May 2001 and March 2002. The underlying hepatic disease was type C liver cirrhosis in all patients. Seven patients had a solitary lesion, and 7 patients had multiple lesions. RFA was chosen for the primary tumor in 5 cases and for a recurrent tumor in 9 cases. Three cases of well differentiated HCC were included. Transcatheter arterial embolization (TAE) was performed in 10 cases simultaneously. Nine patients received RFA under general anesthesia (open laparotomy: 5 cases, transthoracic: 1 case, CT guided: 2 cases, US guided: 1 case) and 5 patients under local anesthesia (CT guided: 2 cases, US guided: 3 cases). RFA was performed for 12 minutes in each session and the mean number of sessions per patient was 3.2. Excellent ablation was achieved in all cases according CT evaluation, and no additional therapy was needed. No recurrences have been found in any cases so far. RFA for HCC achieved excellent therapeutic effect in combination with other therapies as multimodal therapy.

Original languageEnglish
Pages (from-to)2242-2245
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume29
Issue number12
Publication statusPublished - Nov 2002

Fingerprint

Hepatocellular Carcinoma
Therapeutic Uses
Local Anesthesia
Liver Cirrhosis
Laparotomy
General Anesthesia
Neoplasms
Therapeutics
Recurrence
Liver

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Inagaki, M., Yagi, T., Sadamori, H., Matsuda, H., Matsukawa, H., Ishikawa, T., ... Kanazawa, S. (2002). Radiofrequency ablation for hepatocellular carcinoma. Gan to kagaku ryoho. Cancer & chemotherapy, 29(12), 2242-2245.

Radiofrequency ablation for hepatocellular carcinoma. / Inagaki, Masaru; Yagi, Takahito; Sadamori, Hiroshi; Matsuda, Hiroaki; Matsukawa, Hiroyoshi; Ishikawa, Takashi; Tanaka, Noriaki; Mimura, Hidefumi; Yasui, Kotaro; Kanazawa, Susumu.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 29, No. 12, 11.2002, p. 2242-2245.

Research output: Contribution to journalArticle

Inagaki, M, Yagi, T, Sadamori, H, Matsuda, H, Matsukawa, H, Ishikawa, T, Tanaka, N, Mimura, H, Yasui, K & Kanazawa, S 2002, 'Radiofrequency ablation for hepatocellular carcinoma', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 29, no. 12, pp. 2242-2245.
Inagaki M, Yagi T, Sadamori H, Matsuda H, Matsukawa H, Ishikawa T et al. Radiofrequency ablation for hepatocellular carcinoma. Gan to kagaku ryoho. Cancer & chemotherapy. 2002 Nov;29(12):2242-2245.
Inagaki, Masaru ; Yagi, Takahito ; Sadamori, Hiroshi ; Matsuda, Hiroaki ; Matsukawa, Hiroyoshi ; Ishikawa, Takashi ; Tanaka, Noriaki ; Mimura, Hidefumi ; Yasui, Kotaro ; Kanazawa, Susumu. / Radiofrequency ablation for hepatocellular carcinoma. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2002 ; Vol. 29, No. 12. pp. 2242-2245.
@article{4b845817bca94a93adb69258daca5315,
title = "Radiofrequency ablation for hepatocellular carcinoma",
abstract = "We performed radiofrequency ablation (RFA) for 14 patients with hepatocellular carcinoma (HCC) between May 2001 and March 2002. The underlying hepatic disease was type C liver cirrhosis in all patients. Seven patients had a solitary lesion, and 7 patients had multiple lesions. RFA was chosen for the primary tumor in 5 cases and for a recurrent tumor in 9 cases. Three cases of well differentiated HCC were included. Transcatheter arterial embolization (TAE) was performed in 10 cases simultaneously. Nine patients received RFA under general anesthesia (open laparotomy: 5 cases, transthoracic: 1 case, CT guided: 2 cases, US guided: 1 case) and 5 patients under local anesthesia (CT guided: 2 cases, US guided: 3 cases). RFA was performed for 12 minutes in each session and the mean number of sessions per patient was 3.2. Excellent ablation was achieved in all cases according CT evaluation, and no additional therapy was needed. No recurrences have been found in any cases so far. RFA for HCC achieved excellent therapeutic effect in combination with other therapies as multimodal therapy.",
author = "Masaru Inagaki and Takahito Yagi and Hiroshi Sadamori and Hiroaki Matsuda and Hiroyoshi Matsukawa and Takashi Ishikawa and Noriaki Tanaka and Hidefumi Mimura and Kotaro Yasui and Susumu Kanazawa",
year = "2002",
month = "11",
language = "English",
volume = "29",
pages = "2242--2245",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - Radiofrequency ablation for hepatocellular carcinoma

AU - Inagaki, Masaru

AU - Yagi, Takahito

AU - Sadamori, Hiroshi

AU - Matsuda, Hiroaki

AU - Matsukawa, Hiroyoshi

AU - Ishikawa, Takashi

AU - Tanaka, Noriaki

AU - Mimura, Hidefumi

AU - Yasui, Kotaro

AU - Kanazawa, Susumu

PY - 2002/11

Y1 - 2002/11

N2 - We performed radiofrequency ablation (RFA) for 14 patients with hepatocellular carcinoma (HCC) between May 2001 and March 2002. The underlying hepatic disease was type C liver cirrhosis in all patients. Seven patients had a solitary lesion, and 7 patients had multiple lesions. RFA was chosen for the primary tumor in 5 cases and for a recurrent tumor in 9 cases. Three cases of well differentiated HCC were included. Transcatheter arterial embolization (TAE) was performed in 10 cases simultaneously. Nine patients received RFA under general anesthesia (open laparotomy: 5 cases, transthoracic: 1 case, CT guided: 2 cases, US guided: 1 case) and 5 patients under local anesthesia (CT guided: 2 cases, US guided: 3 cases). RFA was performed for 12 minutes in each session and the mean number of sessions per patient was 3.2. Excellent ablation was achieved in all cases according CT evaluation, and no additional therapy was needed. No recurrences have been found in any cases so far. RFA for HCC achieved excellent therapeutic effect in combination with other therapies as multimodal therapy.

AB - We performed radiofrequency ablation (RFA) for 14 patients with hepatocellular carcinoma (HCC) between May 2001 and March 2002. The underlying hepatic disease was type C liver cirrhosis in all patients. Seven patients had a solitary lesion, and 7 patients had multiple lesions. RFA was chosen for the primary tumor in 5 cases and for a recurrent tumor in 9 cases. Three cases of well differentiated HCC were included. Transcatheter arterial embolization (TAE) was performed in 10 cases simultaneously. Nine patients received RFA under general anesthesia (open laparotomy: 5 cases, transthoracic: 1 case, CT guided: 2 cases, US guided: 1 case) and 5 patients under local anesthesia (CT guided: 2 cases, US guided: 3 cases). RFA was performed for 12 minutes in each session and the mean number of sessions per patient was 3.2. Excellent ablation was achieved in all cases according CT evaluation, and no additional therapy was needed. No recurrences have been found in any cases so far. RFA for HCC achieved excellent therapeutic effect in combination with other therapies as multimodal therapy.

UR - http://www.scopus.com/inward/record.url?scp=0036831768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036831768&partnerID=8YFLogxK

M3 - Article

C2 - 12484046

AN - SCOPUS:0036831768

VL - 29

SP - 2242

EP - 2245

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -